DJIA 18,053.71 23.50 0.13%
NASDAQ 4,806.86 33.39 0.70%
S&P 500 2,088.77 6.89 0.33%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

63.65 4.16 (6.99%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ISIS $63.65 6.99%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $61.20
Previous Close $59.49
Daily Range $61.00 - $63.98
52-Week Range $22.25 - $67.12
Market Cap $7.5B
P/E Ratio -72.55
Dividend (Yield) $0.00 (0.0%)
Volume 2,822,399
Average Daily Volume 2,861,212
Current FY EPS -$0.53

Sector

Healthcare

Industry

Drugs

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website: http://www.isispharm.com/

News & Commentary Rss Feed

3 Drugmakers Facing a Pivotal 2015

Isis Pharmaceuticals, PTC Therapeutics, and GW Pharmaceuticals all expect 2015 to be a pivotal year in their drive toward becoming commercially viable entities. Should investors jump in before the catalysts spark?

iShares Russell 2000 ETF Experiences Big Outflow

Isis Pharmaceuticals (ISIS) Showing Signs Of A Dead Cat Bounce Today

Biotech Stocks Sell Off, ETFs Fall Over 5%

Worst Performing Industries For December 23, 2014

Mid-Morning Market Update: Markets Mostly Higher; Walgreen Profit Beats Expectations

Isis Pharmaceuticals (ISIS) Stock: Weak On High Volume Today

Why Isis Pharmaceuticals (ISIS) Stock Might be a Great Pick - Tale of the Tape

Why Isis Pharmaceuticals (ISIS) Stock Might be a Great Pick - Tale of the Tape

IWM, HEZU: Big ETF Inflows

Cramer: ‘Downside’ to Biotech as ImmunoGen Stock Cut in Half

See More ISIS News...

ISIS's Top Competitors

ISIS $63.65 (6.99%)
Current stock: ISIS
AMGN $163.46 (1.74%)
Current stock: AMGN
GILD $93.79 (2.74%)
Current stock: GILD
BIIB $342.40 (0.44%)
Current stock: BIIB